Compounds of Formula I: in which R1, R2, R3, R4 and R10 have the meanings given in the specification, are receptor tyrosine inhibitors useful in the treatment of diseases mediated by PIM-1 and/or PIM-2 and/or PIM-3 kinases.
式I的化合物:其中R1、R2、R3、R4和R10的含义如规范中所述,在通过
PIM-1和/或
PIM-2和/或
PIM-3激酶介导的疾病治疗中有用的受体
酪氨酸激酶
抑制剂。